Opens in a new tab

Edwards Lifesciences v Meril Italy (CFI, 13 November 2023)

Date13 November 2023
CourtCFI
DivisionParis (FR) Central Division - Seat
Type of actionPreliminary objection
Case number(s)UPC_CFI_255/2023
Registry referenceORD_578356/2023 · UPC_CFI_255/2023
PartiesEdwards Lifesciences Corporation v. Meril Italy srl

Official decision (PDF) · UPC registry entry

Case timeline

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By an order of 13 November 2023 (UPC_CFI_255/2023, ACT_551308/2023, App_572915/2023), the judge-rapporteur of panel 2 of the Paris Central Division (P. Catallozzi) rejected the Preliminary objection of Edwards Lifesciences Corporation, which argued that Meril Italy srl’s revocation action against EP 3 646 825 had to be brought before the Munich Local Division, where an infringement action was pending against Meril Life Sciences and Meril GmbH. He also rejected the request for security for costs.

Question

Is a separate subsidiary of the group sued for infringement the « same party » within Art. 33(4) UPCA, so that the central division lacks competence?

Decision

As the Agreement does not define a party, the question is one for national law, here Italian law, under which legal persons with separate personality are different parties, whatever their shareholding links (paragraphs 35 to 43). The CJEU case law on lis pendens does not apply, the Agreement having its own rules, and the exception to the central division’s competence for revocation is to be construed narrowly (paragraphs 44 to 55). The straw company argument fails for want of evidence of an arrangement shifting the effects of the action onto another entity (paragraphs 56 to 69). The risk of conflicting decisions is addressed by the Agreement’s tools (referral, stay), and multiple actions by linked companies are not abusive in themselves (paragraphs 70 to 84). Security for costs may be sought with the Preliminary objection, but share capital of EUR 10,000 and the lack of activity are not enough, given membership of the group (paragraphs 88 to 91).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 33(2) to (6), Art. 46, Art. 47(6) and Art. 69(4)
Rules of Procedure
Rules 19, 48, 158, 295, 302, 303, 331 and 340
European Patent Convention
Art. 68
Regulation (EU) No 1215/2012
Art. 29

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Decisions in the same proceedings

Going further

Lexicon: Local and central divisions (UPC).

Dhenne Avocats blog: The Transitional Period and the UPC: Coordinating Two Judicial Orders.

Publications by Matthieu Dhenne: Pleading the Long Arm: What a UPC Statement of Claim Must Carry Beyond Jurisdiction, Valeo v. Bosch and the Redistribution of Cases Within the UPC (Kluwer Patent Blog).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CFI_255/2023 official number

Follow this case

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

  1. 13 November 2023 Edwards Lifesciences v Meril Italy (CFI, 13 November 2023) Preliminary objection · UPC_CFI_255/2023
  2. 27 February 2024 Meril Italy v Edwards Lifesciences (CFI, UPC_CFI_255/2023, ORD_7184/2024, 27 February 2024) Generic application · UPC_CFI_255/2023
  3. 27 February 2024 Meril Italy v Edwards Lifesciences (CFI, UPC_CFI_255/2023, ORD_7184/2024, 27 February 2024, doc. 2) Generic application · UPC_CFI_255/2023
  4. 30 April 2024 Edwards Lifesciences v Meril Italy (CFI, 30 April 2024) Generic application · UPC_CFI_255/2023

    La demande ultérieure de modification du brevet est admise et Meril dispose d'un mois pour une défense complémentaire. La duplique est refusée.

What the record states

Nature of the act
Preliminary objection
Outcome (Dhenne Avocats summary)
La division centrale reste compétente pour l'action en nullité de Meril Italy, filiale distincte des défenderesses à l'action en contrefaçon munichoise. La garantie pour les frais est refusée.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 3 646 825
A system comprising a prosthetic valve and a delivery catheter
recorded proprietor: Edwards Lifesciences Corp
Mentioned in the analysis (role not qualified)
Also mentioned in 32 other decision(s): Edwards Lifesciences v Meril Life Sciences (CFI, 15 November 2024) · Meril Italy v Edwards Lifesciences (CFI, 19 July 2024) · Meril v Edwards Lifesciences (CFI, 19 July 2024) · Meril Italy v Edwards Lifesciences (CoA, 25 November 2025) · Edwards Lifesciences v Sintec (CFI, 5 September 2025) · Meril Italy v SWAT Medical (CoA, 5 May 2025) · Meril v SWAT Medical (CoA, 5 May 2025) · Meril Life Sciences v SWAT Medical (CoA, 5 May 2025)
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.